| Literature DB >> 23506076 |
Simone Balzer1, Veronika Kucharova, Judith Megerle, Rahmi Lale, Trygve Brautaset, Svein Valla.
Abstract
BACKGROUND: Production of recombinant proteins in bacteria for academic and commercial purposes is a well established field; however the outcomes of process developments for specific proteins are still often unpredictable. One reason is the limited understanding of the performance of expression cassettes relative to each other due to different genetic contexts. Here we report the results of a systematic study aiming at exclusively comparing commonly used regulator/promoter systems by standardizing the designs of the replicon backbones.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23506076 PMCID: PMC3621392 DOI: 10.1186/1475-2859-12-26
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Illustration showing how the different constructs in the study were generated based on pSB-M1b. The upper part shows how the alternative regulator/promoter systems were incorporated. pSB-M1b-1-17 contains a variant of the Pm core promoter termed ML1-17 (see text). The lower part shows the oriV/trfA region in pSB-M1b that was replaced with the pMB1 ori described in Table 1.
Plasmids used in this study
| pTA16/pSB-M1bb | [ | ||
| pET16b | IPTG-inducible | Novagen | |
| pBAD/gIII_calmodulin | L-arabinose- inducible | Invitrogen | |
| pTrc99A | IPTG- inducible | Pharmacia | |
| pIB11- | pIB11 [ | unpublished | |
| pBAD24-GFP | pBAD24 with | [ | |
| pHOG-173-2-5-AP | pHOG plasmid with | unpublished | |
| pMA-GH | pMA vector (GeneArt®, Invitrogen) with | unpublished | |
| pMA-T-IL-1RA | pMA vector (GeneArt®, Invitrogen) with | unpublished | |
| pSB-P0x | pSB-M1b variants with combinations of different features: | | |
| | P… regulator/promoter system | M… | |
| | | M-1-17… | |
| | | E… | |
| | | T… | |
| | | B… | |
| | 0… origin of replication | 1… RK2 replicon | |
| | | 2… pMB1 replicon | |
| | x… reporter gene | b… | |
| | | l… | |
| | | s… | |
| | | g… | |
| | | h | |
| | | r | This study |
| e.g. pSB-M2l | This study | ||
abla: β- lactamase gene; lucS: synthetic luciferase gene; scFv173-2-5-phoA: single-chain antibody fragment 173-2-5 alkaline phosphatase fusion gene; gfpmut3: gene for the optimized green fluorescent protein mutant 3; GH1: synthetic gene for human growth hormone, IL1RN: synthetic gene for human interleukin 1 receptor antagonist.
b pTA16 was named pSB-M1g in this study for consistency purposes.
Properties of the proteins selected as expression reporters
| Luciferase | reporter protein, ~ 60.8 kDa, cytoplasmic localization, generally low expression, rather easy to detect, very sensitive detection via bioluminescence assay |
| scFv173-2-5-AP | industrially relevant protein, ~77.2 kDa, fusion protein, disulfide bonds, translocated to the periplasm, detectable through APa fusion, AP needs to be translocated to be active [ |
| GFP | reporter protein, ~ 26.9 kDa, cytoplasmic localization, stable, known to be produced virtually only in its soluble form [ |
| HGH | industrially relevant protein, ~25.1 kDa, cytoplasmic localization, usually expressed in |
| IL-1RA | industrially relevant protein, ~20.1 kDa, cytoplasmic localization, usually expressed in |
aAlkaline phosphatase.
Figure 2Maximum expression of three different genes placed under control of different regulator/promoter systems. Data represent relative expression levels under induced conditions where the activity of M1x (gene x under conrol of the Pm wildtype promoter, RK2 replicon) was set to 1.0. Expression was induced in a way that activity levels were maximized: 2 mM m-toluate for strains harboring XylS/Pm- based constructs, 1 mM IPTG for those with LacI/PT7lac, 0.2 mM IPTG for LacI/Ptrc and 0.015% L-arabinose for AraC/PBAD. The following E. coli strains were used as expression hosts. Panels A-C: ER2566. Panels D-F: DH10B. The naming code is the following: The capital letter represents the regulator/promoter system and the digit represents the origin of replication; for details see Table 1. The data presented are from independent biological replica.
Figure 3Correlation between the accumulated transcript and protein produced after induction. The five proteins (Panels A-E) were expressed in E. coli ER2566 harboring pMB1-based plasmids. Five hours after induction, samples were collected for relative quantification real-time RT-PCR (qRT-PCR) and SDS-PAGE. Accumulated transcript data were correlated to the XylS/Pm system (M2x; gene x under conrol of the Pm wildtype promoter, pMB1 replicon). The total protein fractions were separated into the soluble supernatant and the insoluble pellet fraction after sonication and separated through SDS-PAGE followed by staining with Coomassie Brilliant blue. Further information about the naming system can be found in Table 1. Neg: Negative control.
Figure 4Investigation of the tightness of different regulator/promoter systems in combination with the pMB1 replicon. Protein activity was determined in parallel with induced cultures at the time point corresponding to five hours after induction. The data presented are from independet biological replica. The following E. coli strains were used as expression hosts. Panels A-C: ER2566. Panels D-E: DH10B. The capital letters represent the regulator/ promoter systems according to Table 1. Uninduced expression of GFP in DH10B was very close to the detection limit in LB medium and was left out.
Figure 5Theoretical analysis of the translational start site by calculating the translation initiation rate (TIR). The complete 5′-UTR sequences in combination with the first 50 nucleotides of the respective genes (luc (Panel A), scFv173-2-5-phoA (B), gfpmut3 (C), GH1 (D) and IL1RN (E)) were used as input sequences for the RBS calculator [54].
Figure 6Analysis of the distribution of expression using flow cytometry. Strains were grown under standard conditions. At the time point of induction (t= 0 min) and at several points afterwards (t= 20–300 min), samples were collected, snap-frozen, and collectively analyzed with a flow cytometer. The spread is represented by the coefficient of variation (CV). Panels A-D: ER2566, Panel E: DH10B.
Summary of the findings derived from the comparative expression study
| XylS regulator | LacI regulator | LacI regulator | AraC regulator | | |
| | | ||||
| | | CAP binding site | | CAP binding site | |
| none | strain supplying T7 polymerase | none | | ||
| | | (and lysozyme)a | | | |
| none | (glucose)b | none | (glucose)b | [ | |
| 0.001 - 2.0 mM | 0.05 - 2.0 mM | 0.05 - 2.0 mM | 0.001% - 1% | [ | |
| low - high | intermediate - high | low - intermediate | intermediate - high | This study | |
| low - high | low - high | High | low | This study | |
| intermediate | intermediate-high | Low | high | This study | |
| low - intermediate | high | below detection - intermediate | intermediate | This study | |
| weak - intermediate | intermediate - strong | weak - intermediate | strong | This study | |
| homogeneous populations | mixed populations | homogeneous populations | mixed populations | This study | |
| high level expression | high level expression | (high level expression)c | high level expression | | |
| | expression of toxic proteins | (expression of toxic proteins)c | (metabolic engineering)c | expression of toxic proteins | |
| metabolic engineering | (metabolic engineering)c | This study | |||
a Expression of lysozyme, the natural inhibitor of T7 RNA polymerase, reduces the basal transcription from P.
b Supplementing glucose leads to catabolite repression which reduces basal transcription levels.
c Limited suitability. See ‘Results and discussion’ section for detailed information.
Oligonucleotides used in this study
| a) PCR primers | |
| Pwitw4_AscI | AAAGTGAGGGCGCGCCGGTTGATGAGAG |
| Pwitw5_SpeI | ATCCACCGGAACTAGTCCCCTGCTC |
| Pwitw6_badF | AGACTAGTAAGCCCTCCCGTATCGTAGTTA |
| Pwitw6_badR | TGGCGCGCCAGATGCGTAAGGAGAAAATACCG |
| ET_AgeI_fwd | GATGGCCCATATGATATCTCCTTCT |
| ET_NdeI_rev | GATCACCGGTCCAGTGATCGAA |
| BAD_BbsI_fwd | GGCCTTTCGTCTTCCCGGCATCCGCTTACAGACA |
| BAD_NdeI_rev | GACGCCCATATGTAATTCCTCCTGTTAGCCCAAAAAACG |
| TRC_AgeI_fwd1 | TGCATGTGTCACCGGTTTTCACCGTC |
| TRC_NdeI_rev1 | GAGCTCGAATCATATGGTCTGTTTCCTG |
| pelB_fwd | AGCTACATATGAAATACCTATTGCCTACG |
| APhis_rev2 | AGGATCCGAGCCTTTCGTTTTATTGATGC |
| b) qRT-PCR primers | |
| RT-synluc_fwd2 | CCATGGCTTCGGCATGTT |
| RT-synluc_rev2 | ACACGAAAGCCGCAAATCA |
| gfpmut3_fwd1 | CATGGCCAACACTTGTCACT |
| gfpmut3_rev1 | CTGCTTCATGTGATCTGGGTATCT |
| RT-hGH.fwd1 | GCCTGTGTTTTAGCGAAAGCAT |
| RT-hGH.rev1 | AGATTGCTTTTCTGCTGGGTTT |
| RT-IL-1-RA.fwd1 | ATTGATGTGGTGCCGATTGA |
| RT-IL-1-RA.rev1 | TCAGACACATTTTACCACCATGAA |
| scFv198.fwd | GAAGGGCCGGTTCACCAT |
| scFv255.rev | CATTTGCAGATACAGCGTGTTCT |
| RT-16S-Fwd | ATTGACGTTACCCGCAGAAGAA |
| RT-16S-Rev | GCTTGCACCCTCCGTATTACC |